On June 30, 2017, Plaintiff Sanofi-Aventis U.S. LLC, Sanofi-Aventis Deutschland GMBH and Sanofi Winthrop Industrie filed a second amended and supplemental complaint against Defendant Merck Sharp & Dohme Corp. in the United States District Court for the District of Delaware on June 28, 2017. The patent-at-issue is U.S. Patent Number 9604008 entitled “Drive Mechanisms Suitable for Use in Drug Delivery Devices.” Plaintiffs allege that Defendant’s manufacture, use, sale to sell in the United States, and/or importation into the United States, of its patented insulin glargine injection combination product with pen injector, infringes the patent directly or indirectly. The case is captioned Sanofi-Aventis US LLC et al. v. Merck Sharp & Dohme Corp., DED-1-16-cv-00812.
By: Katherine Kim